Clinical Oncology
Volume 16, Issue 8 , Pages 549-560, December 2004

The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies

  • Graeme Morgan

      Affiliations

    • Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia
    • Corresponding Author InformationAuthor for correspondence: Dr Graeme W. Morgan, Director, Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney NSW 2065, Australia. Tel: +61-2-9926-5010; Fax: +61-2-9906-4150.
    • ,
  • Robyn Ward

      Affiliations

    • Department of Medical Oncology, St Vincent's Hospital, Sydney, NSW, Australia
    • ,
  • Michael Barton

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Health Service, Sydney, NSW, Australia

Received 18 August 2003; received in revised form 20 April 2004; accepted 3 June 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(04)00222-5

doi:10.1016/j.clon.2004.06.007

Clinical Oncology
Volume 16, Issue 8 , Pages 549-560, December 2004

Article Tools